Regencell Bioscience Holdings Limited
NASDAQ:RGC
15.29 (USD) • At close July 16, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2,341.8 | 0 | 0 | 0 | -2,341.8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0 | 0 | 0 | 0 | 0.77 | 0 | 0 | 0 | 0.604 | 0 | 0 | 0 | 877.7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 0 | 0 | 0 | 0 | -0.77 | 0 | 0 | 0 | -2,342.404 | 0 | 0 | 0 | -3,219.5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1.375 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 0.581 | 0 | 0 | 0 | 0.231 | 0 | 1.35 | 0.001 | 1.397 | 0.001 | 1.115 | 0.001 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 1.843 | 0.001 | 0.001 | 0.001 | 1.843 | 0.001 | 2.079 | 0.001 | 1.958 | 0.001 | 2.544 | 0.001 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Expenses
| 0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -285.7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 2.425 | 0.001 | 0.001 | 0.001 | 2.074 | 0.001 | 3.43 | 0.002 | 3.354 | 0.002 | 3.659 | 0.002 | 0.001 | 0.001 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income
| -2.425 | -0.001 | -0.001 | -0.001 | -2.844 | -0.001 | -3.43 | -0.002 | -3.959 | -0.002 | -3.659 | -0.002 | -0.001 | -0.001 | -0 | -0 | -0 | -0 | -0 | -0 |
| Operating Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.002 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 0.248 | 0 | -1.03 | -1.092 | 0.097 | -1.372 | 0.114 | -1.656 | -1.956 | -1.966 | 0 | -1.828 | 0.506 | -0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax
| -2.177 | -0.001 | -0.001 | -0.001 | -2.747 | -0.001 | -3.315 | -0.002 | -3.936 | -0.002 | -3.659 | -0.002 | -0.001 | -0.001 | -0 | -0 | -0 | -0 | -0 | -0 |
| Income Before Tax Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.002 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0 | 0 | -0.119 | -0 | 0 | -0 | 0 | -0 | -0 | -0 | -0 | -0 | -70.9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income
| -2.235 | -0.001 | -0.001 | -0.001 | -2.644 | -0.001 | -3.227 | -0.002 | -3.936 | -0.002 | -3.659 | -0.002 | -0.001 | -0.001 | -0 | -0 | -0 | -0 | -0 | -0 |
| Net Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.002 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -0.004 | -0 | -0 | -0 | -0.005 | -0 | -0.007 | -0 | -0.008 | -0 | -0.007 | -0 | -0 | -0 | -0 | -0 | -0.001 | -0.001 | -0 | -0 |
| EPS Diluted
| -0.004 | -0 | -0 | -0 | -0.005 | -0 | -0.007 | -0 | -0.008 | -0 | -0.007 | -0 | -0 | -0 | -0 | -0 | -0.001 | -0.001 | -0 | -0 |
| EBITDA
| -2.177 | -0.001 | -2.186 | -1.083 | -1.976 | -1.385 | -3.43 | -1.677 | -3.331 | -1.973 | -3.659 | -1.823 | -0.5 | -0.5 | -0.178 | -0.178 | -0.255 | -0.257 | -0.149 | -0.149 |
| EBITDA Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.001 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |